The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Lapchak, Peter H ^a   Ioannou, Antonis ^a   Rani, Poonam ^a   Lieberman, Linda A ^a   Yoshiya, Kazuhisa ^a   Kannan, Lakshmi ^a   Dalle Lucca, Jurandir J ^c   Kowalska, M Anna ^b   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN A; MESSENGER RNA; THROMBOCYTE FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; IMMUNOGLOBULIN DEPOSITION; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; LUNG INJURY; MESENTERIC ISCHEMIA; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; THROMBOCYTE TRANSFUSION; UPREGULATION;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; IMMUNOGLOBULINS; INTESTINES; LUNG; MALE; MESENTERIC ARTERIES; MESENTERY; MICE; MICE, KNOCKOUT; MONOCYTES; NEUTROPHIL INFILTRATION; PLATELET FACTOR 4; PLATELET TRANSFUSION; REPERFUSION INJURY;

MUS;

EID: 84863652912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039934     Document Type: Article

References (51)

1. Diepenhorst GM, van Gulik TM, Hack CE, (2009) Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg 249: 889-899.
2. Ioannou A, Dalle Lucca J, Tsokos GC, (2011) Immunopathogenesis of ischemia/reperfusion-associated tissue damage. Clin Immunol 141: 3-14.
3. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, et al. (1999) Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86: 938-942.
4. Chen J, Crispin JC, Tedder TF, Dalle Lucca J, Tsokos GC, (2009) B cells contribute to ischemia/reperfusion-mediated tissue injury. J Autoimmun 32: 195-200.
5. Edgerton C, Crispin JC, Moratz CM, Bettelli E, Oukka M, et al. (2009) IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol 130: 313-321.
6. Matthijsen RA, Huugen D, Hoebers NT, de Vries B, Peutz-Kootstra CJ, et al. (2007) Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol 171: 1743-1752.
7. Padilla ND, van Vliet AK, Schoots IG, Valls Seron M, Maas MA, et al. (2007) C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Surgery 142: 722-733.
8. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, et al. (2004) Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 101: 3886-3891.
9. Zhang M, Carroll MC, (2007) Natural antibody mediated innate autoimmune response. Mol Immunol 44: 103-110.
10. Snoeck V, Peters IR, Cox E, (2006) The IgA system: a comparison of structure and function in different species. Vet Res 37: 455-467.
11. Yoshiya K, Lapchak PH, Thai TH, Kannan L, Rani P, et al. (2011) Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 301: G1020-1030.
12. Schmitt-Sody M, Metz P, Klose A, Gottschalk O, Zysk S, et al. (2007) In vivo interactions of platelets and leucocytes with the endothelium in murine antigen-induced arthritis: the role of P-selectin. Scand J Rheumatol 36: 311-319.
13. Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, et al. (2010) Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med 2: 47ra63.
14. Collins CE, Rampton DS, (1997) Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 11: 237-247.
15. Kirk AD, Morrell CN, Baldwin WM, 3rd (2009) Platelets influence vascularized organ transplants from start to finish. Am J Transplant 9: 14-22.
16. Lapchak PH, Kannan L, Ioannou A, Rani P, Karian P, et al. (2012) Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 302: G888-897.
17. Rendu F, Brohard-Bohn B, (2001) The platelet release reaction: granules' constituents, secretion and functions. Platelets 12: 261-273.
18. Walz DA, Wu VY, de Lamo R, Dene H, McCoy LE, (1977) Primary structure of human platelet factor 4. Thromb Res 11: 893-898.
19. Eslin DE, Zhang C, Samuels KJ, Rauova L, Zhai L, et al. (2004) Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 104: 3173-3180.
20. Hermodson M, Schmer G, Kurachi K, (1977) Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. J Biol Chem 252: 6276-6279.
21. Han ZC, Lu M, Li J, Defard M, Boval B, et al. (1997) Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood 89: 2328-2335.
22. Watson JB, Getzler SB, Mosher DF, (1994) Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest 94: 261-268.
23. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, et al. (2009) Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15: 97-103.
24. Petersen F, Ludwig A, Flad HD, Brandt E, (1996) TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J Immunol 156: 1954-1962.
25. Pervushina O, Scheuerer B, Reiling N, Behnke L, Schroder JM, et al. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J Immunol 173: 2060-2067.
26. Fricke I, Mitchell D, Petersen F, Bohle A, Bulfone-Paus S, et al. (2004) Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 18: 1588-1590.
27. Woller G, Brandt E, Mittelstadt J, Rybakowski C, Petersen F, (2008) Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol 83: 936-945.
28. Sachais BS, Turrentine T, Dawicki McKenna JM, Rux AH, Rader D, et al. (2007) Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost 98: 1108-1113.
29. Fujimi S, MacConmara MP, Maung AA, Zang Y, Mannick JA, et al. (2006) Platelet depletion in mice increases mortality after thermal injury. Blood 107: 4399-4406.
30. Gushiken FC, Han H, Li J, Rumbaut RE, Afshar-Kharghan V, (2009) Abnormal platelet function in C3-deficient mice. J Thromb Haemost 7: 865-870.
31. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN, (1970) Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101: 478-483.
32. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, et al. (1996) An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
33. Lasagni L, Grepin R, Mazzinghi B, Lazzeri E, Meini C, et al. (2007) PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion. Blood 109: 4127-4134.
34. von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, et al. (2005) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105: 924-930.
35. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM, (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176: 587-592.
36. Gear AR, Camerini D, (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10: 335-350.
37. Shenkman B, Brill A, Brill G, Lider O, Savion N, et al. (2004) Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alpha. J Thromb Haemost 2: 154-160.
38. Ferroni P, Basili S, Davi G, (2003) Platelet activation, inflammatory mediators and hypercholesterolemia. Curr Vasc Pharmacol 1: 157-169.
39. Cerutti A, Rescigno M, (2008) The biology of intestinal immunoglobulin A responses. Immunity 28: 740-750.
40. Johansson C, Ahlstedt I, Furubacka S, Johnsson E, Agace WW, et al. (2005) Differential expression of chemokine receptors on human IgA+ and IgG+ B cells. Clin Exp Immunol 141: 279-87.
41. Baldwin WM, 3rd, Kuo HH, Morrell CN (2010) Platelets: versatile modifiers of innate and adaptive immune responses to transplants. Curr Opin Organ Transplant.
42. Davi G, Patrono C, (2007) Platelet activation and atherothrombosis. N Engl J Med 357: 2482-2494.
43. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, et al. (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327: 580-583.
44. Yoshida H, Granger DN, (2009) Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis 15: 1245-1255.
45. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, et al. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77-79.
46. Cervi D, Yip TT, Bhattacharya N, Podust VN, Peterson J, et al. (2008) Platelet-associated PF-4 as a biomarker of early tumor growth. Blood 111: 1201-1207.
47. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, et al. (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9: 61-67.
48. Massberg S, Brand K, Gruner S, Page S, Muller E, et al. (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196: 887-896.
49. Bebawy ST, Gorka J, Hyers TM, Webster RO, (1986) In vitro effects of platelet factor 4 on normal human neutrophil functions. J Leukoc Biol 39: 423-434.
50. Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, et al. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95: 1158-1166.
51. Xia CQ, Kao KJ, (2003) Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. Int Immunol 15: 1007-1015.